Finance

Lists
Why is 3G0 up 4.02%?
Dive Deeper
3G0:FRA
Altimmune Inc
€2.02
+4.02%
(+0.078) 1D
Oct 20, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 3G0...
Open
€1.93
High
€2.02
Low
€1.93
Mkt. cap
447.39M
Avg. vol.
218.00
Volume
0.00
52-wk high
€5.32
52-wk low
€1.93
No. of employees
57
Open
€1.93
High
€2.02
Low
€1.93
Mkt. cap
447.39M
Avg. vol.
218.00
Volume
0.00
52-wk high
€5.32
52-wk low
€1.93
No. of employees
57
News stories
From web sources and news partners
About Altimmune Inc
CEOJerry Durso
Employees57
Founded1997
HeadquartersGaithersburg, Maryland, United States
SectorBiotechnology
Websitealtimmune.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.00K
26.00K
-
-
Cost of goods sold
14.96M
18.41M
15.48M
17.86M
Cost of revenue
14.96M
18.41M
15.48M
17.86M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.90M
10.51M
8.05M
7.57M
Operating expense
5.90M
10.51M
8.05M
7.57M
Total operating expenses
20.86M
28.92M
23.54M
25.43M
Operating income
-20.86M
-28.89M
-23.54M
-25.43M
Other non operating income
-86.00K
-27.00K
-152.00K
-25.00K
EBT including unusual items
-19.01M
-27.36M
-22.56M
-22.82M
EBT excluding unusual items
-19.01M
-27.36M
-21.85M
-22.02M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.01M
-27.36M
-22.56M
-22.82M
Net profit margin
-380,280.00%
-105,223.08%
-
-
Earnings per share
-0.21
-0.27
-0.18
-0.12
Interest and investment income
2.43M
2.44M
2.90M
4.53M
Interest expense
-495.00K
-876.00K
-1.07M
-1.10M
Net interest expenses
1.93M
1.56M
1.83M
3.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.83M
-28.87M
-23.51M
-25.41M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps